WallStreetZenWallStreetZen

NASDAQ: MDGL
Madrigal Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MDGL

Based on 7 analysts offering 12 month price targets for Madrigal Pharmaceuticals Inc.
Min Forecast
$225.00-13.44%
Avg Forecast
$332.57+27.94%
Max Forecast
$390.00+50.03%

Should I buy or sell MDGL stock?

Based on 7 analysts offering ratings for Madrigal Pharmaceuticals Inc.
Strong Buy
Strong Buy
3 analysts 42.86%
Buy
4 analysts 57.14%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MDGL stock forecasts and price targets.

MDGL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Oppenheimer
Top 2%
99
BuyMaintains$350.00+34.65%2023-05-16
Canaccord Genuity
Top 24%
77
Strong BuyReiterates$336.00+29.26%2023-05-10
JMP Securities
Top 8%
93
BuyMaintains$390.00+50.03%2023-01-05
UBS
Top 14%
87
Strong BuyMaintains$337.00+29.65%2022-12-21
HC Wainwright & Co.
Top 9%
92
BuyMaintains$225.00-13.44%2022-12-20
Goldman Sachs
Bottom 12%
12
Strong BuyMaintains$375.00+44.26%2022-12-20
SVB Leerink
Top 25%
76
BuyMaintains$315.00+21.18%2022-12-20

1 of 1

Forecast return on equity

Is MDGL forecast to generate an efficient return?
Company
N/A
Industry
0.1%
Market
71.96%

Forecast return on assets

Is MDGL forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

MDGL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MDGL$259.94$332.57+27.94%Strong Buy
PCVX$50.73$62.75+23.69%Strong Buy
ALKS$29.51$33.67+14.09%Buy
HALO$33.57$55.00+63.84%Strong Buy
CRSP$65.00$69.40+6.78%Buy
View Top Biotech Stocks

Madrigal Pharmaceuticals Stock Forecast FAQ

Is Madrigal Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: MDGL) stock is to Strong Buy MDGL stock.

Out of 7 analysts, 3 (42.86%) are recommending MDGL as a Strong Buy, 4 (57.14%) are recommending MDGL as a Buy, 0 (0%) are recommending MDGL as a Hold, 0 (0%) are recommending MDGL as a Sell, and 0 (0%) are recommending MDGL as a Strong Sell.

If you're new to stock investing, here's how to buy Madrigal Pharmaceuticals stock.

What is MDGL's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: MDGL) forecast ROE is N/A, which is considered weak.

What is MDGL's Price Target?

According to 7 Wall Street analysts that have issued a 1 year MDGL price target, the average MDGL price target is $332.57, with the highest MDGL stock price forecast at $390.00 and the lowest MDGL stock price forecast at $225.00.

On average, Wall Street analysts predict that Madrigal Pharmaceuticals's share price could reach $332.57 by May 16, 2024. The average Madrigal Pharmaceuticals stock price prediction forecasts a potential upside of 27.94% from the current MDGL share price of $259.94.

What is MDGL's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: MDGL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.